Review Oncologic, Endocrine & Metabolic: Inhibitors of protein farnesylation: A new approach to cancer chemotherapy
Author:
- 1 December 1995
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 5 (12) , 1269-1285
Abstract
The Ras protein functions at a critical point in the signalling pathway between extracellular growth regulatory messengers and the nuclear factors that are responsible for the initiation of cellular replication. The action of mutant, oncogenic Ras proteins is implicated in a significant fraction of human tumours. All Ras proteins appear to require post-translational lipidation for their function. The key lipidation event is the attachment of a farnesyl unit to a cysteine near the carboxyl terminus of the protein. Recently, the possibility of interfering with Ras-mediated cell transformation through inhibition of protein farnesylation has attracted significant attention. This review surveys the types of compounds that are reported to inhibit the enzyme protein farnesyltransferase and the biological effects of these compounds in vitro and in vivo.Keywords
This publication has 56 references indexed in Scilit:
- Cylindrol A: A Novel Inhibitor of Ras Farnesyl-Protein Transferase from Cylindrocarpon lucidumTetrahedron Letters, 1995
- Stereochemistry of the benzodiazepine based Ras farnesyltransferase inhibitorsBioorganic & Medicinal Chemistry Letters, 1995
- Actinoplanic Acid A: A Macrocyclic Polycarboxylic Acid Which Is a Potent Inhibitor of Ras Farnesyl-Protein TransferaseJournal of the American Chemical Society, 1994
- Rational design of potent carboxylic acid based bisubstrate inhibitors of ras farnesyl protein transferaseBioorganic & Medicinal Chemistry Letters, 1994
- Phenol based tripeptide inhibitors of ras farnesyl protein transferaseBioorganic & Medicinal Chemistry Letters, 1994
- Raf meets Ras: completing the framework of a signal transduction pathwayTrends in Biochemical Sciences, 1994
- Peptide based P21RAS farnesyl transferase inhibitors: systematic modification of the tetrapeptide CA1A2X motifBioorganic & Medicinal Chemistry Letters, 1994
- Zaragozic Acids D and D2: Potent Inhibitors of Squalene Synthase and of Ras Farnesyl-Protein TransferaseJournal of Natural Products, 1993
- Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal CellsScience, 1993
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993